Testing strategies in immunotoxicology

Toxicology Letters

Volumn 102-103, Issue , 1998, Pages 257-260

  Pallardy, M ^a   Kerdine, S ^a   Lebrec, H ^a  

^a INSERM   (France)

Author keywords

Autoimmunity; Hypersensitivity; Immunotoxicology

Indexed keywords

CONFERENCE PAPER; DRUG DEVELOPMENT; DRUG SCREENING; GENOTOXICITY; HUMAN; IMMUNOTOXICITY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; HUMANS; IMMUNE SYSTEM; TOXICOLOGY;

EID: 0032421339     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(98)00315-4     Document Type: Conference Paper

References (17)

1. Aiba, S., Terunuma, A., Manome, H., Tagami, H., 1997. Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co-stimulatory molecules. Eur. J. Immunol. 27, 3031-3038.
2. Albers, R., Broeders, A., van der Pijl, A., Seinen, W., Pieters, R., 1997. The use of reporter antigens in the popliteal lymph node assay to assess immunomodulation by chemicals. Tox. Appl. Pharmacol. 143, 102-109.
3. Bigazzi, P.E., 1997. Autoimmunity caused by xenobiotics. Toxicology 119, 1-21.
4. De Maria, R., Testi, R., 1998. Fas-FasL interactions: a common pathogenic mechanism in organ-specific autoimmunity. Immunol. Today 19, 121-125.
5. De Waal, E.J., Schuurman, H.J., Hendriksen, C., Elvers, B., Van Dijk, A., Van Loveren, H., 1992. Effects of subcutaneous vs. intravenous administration of cyclosporine on rat thymic histology and pharmacokinetics. Int. J. Immunopharmacol. 14, 1101-1105.
6. Elkon, K.B., Marshak-Rothstein, A., 1996. B cells in systemic autoimmune disease: recent insights from Fas-deficient mice and men. Curr. Opin. Immunol. 8, 852-859.
7. Gerberick, G.F., Cruse, L.W., Miller, C.M., Sikorski, E.E., Ridder, G.M., 1997. Selective modulation of T cell memory markers CD62L and CD44 on murine draining lymph nodes cells following allergen and irritant treatment. Tox. Appl. Pharmacol. 146, 1-10.
8. Islam, Z., Nagase, M., Yoshizawa, T., Yamauchi, K., Sakato, N., 1998. T-2 toxin induces thymic apoptosis in vivo in mice. Tox. Appl. Pharmacol. 148, 205-214.
9. Kerdine, S., Lebrec, H., Bertoglio, J., Pallardy, M., 1996a. Interleukin-4 plays a dominant role in Th1- or Th-2 like responses during the primary immune response to penicillin. Mol. Immunol. 33, 71-77.
10. Kerdine, S., Pallardy, M., Lamanètre, S., Bertoglio, J., Lebrec, H., 1996b. Interleukin-10 and interleukin-4 have similar effects on hapten-specific primary antibody responses to penicillin in vivo. Eur. J. Immunol. 26, 2890-2894.
11. Kimber, I., Hilton, J., Dearman, R.J., 1995. An international evaluation of the murine local lymph node assay and comparison of modified procedures. Toxicology 103, 63-73.
12. Kühn, U., Brand, P., Willemsen, J., 1998. Induction of tyrosine phosphorylation in human MHC class II-positive antigen-presenting cells by stimulation with contact sensitizers. J. Immunol. 160, 667-673.
13. Lebrec, H., Blot, C., Pequet, S., Roger, R., Bohuon, C., Pallardy, M., 1994. Immunotoxicological investigation using pharmaceutical drugs: In vivo evaluation of immune effects. Fund. Appl. Toxicol. 23, 159-168.
14. Luster, M.I., Portier, C., Pait, D.G., 1992. Risk assessment in immunotoxicology. I Sensitivity and predictability of immune tests. Fund. Appl. Toxicol. 18, 200-210.
15. Meyaard, L., Hovenkamp, E., Keet, I.P.M., 1996. Single cell analysis of IL-4 and IFN-γ production by T cells from HIV-infected individuals. J. Immunol. 157, 2712-2718.
16. Osborne, B.A., 1996. Apoptosis and maintenance of homeostasis in the immune system. Curr. Opin. Immunol. 8, 245-254.
17. Tolosa, E., King, L.B., Ashwell, J.D., 1998. Thymocyte glucocorticoid resistance alters positive selection and inhibits autoimmunity and lymphoproliferative disease in MRL-lpr/lpr mice. Immunity 8, 67-76.